share_log

Aehr Test Systems Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Provides Fiscal 2025 Full Year Financial Guidance

Aehr Test Systems Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Provides Fiscal 2025 Full Year Financial Guidance

aehr test systems報告2024財年第四季度和全年財務業績,並提供2025全年財務指導。
Accesswire ·  07/16 16:05

FREMONT, CA / ACCESSWIRE / July 16, 2024 / Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced financial results for its fiscal 2024 fourth quarter and full year ended May 31, 2024.

2024年5月31日結束的財年第四季度和全年財務業績公佈後,供應半導體測試和烤機設備的全球供應商Aehr Test Systems(納斯達克:AEHR)今天宣佈其財務業績。

Fiscal Fourth Quarter Financial Results:

財政第四季度財務業績:

  • Net revenue was $16.6 million, compared to $22.3 million in the fourth quarter of fiscal 2023

  • GAAP net income was $23.9 million, or $0.81 per diluted share, which includes the impact of a tax benefit resulting from the release of the Company's full income tax valuation allowance of approximately $20.8 million, compared to GAAP net income of $6.1 million, or $0.21 per diluted share, in the fourth quarter of fiscal 2023.

  • Non-GAAP net income was $24.7 million, or $0.84 per diluted share, which includes the tax benefit and excludes acquisition related costs and the impact of stock-based compensation, compared to non-GAAP net income of $6.8 million, or $0.23 per diluted share, in the fourth quarter of fiscal 2023.

  • Bookings were $4.0 million for the quarter

  • Backlog as of May 31, 2024, was $7.3 million. Effective backlog, which includes all orders received since the end of the fourth quarter, is $20.8 million.

  • Total cash and cash equivalents as of May 31, 2024 were $49.2 million, up from $47.6 million at February 29, 2024

  • 淨營業收入爲1660萬美元,而在2023財年第四季度爲2230萬美元。

  • 根據GAAP,淨利潤爲2390萬美元,每股攤薄盈利爲0.81美元,其中包括公司扣除的約2080萬美元所得稅收益的影響,而在2023財年第四季度的根據GAAP的淨利潤爲610萬美元,每股攤薄盈利爲0.21美元。

  • 根據非GAAP,淨利潤爲2470萬美元,每股攤薄盈利爲0.84美元,其中包括所得稅收益,並排除收購相關成本和股票補償的影響,而在2023財年第四季度的非GAAP淨利潤爲680萬美元,每股攤薄盈利爲0.23美元。

  • 本季度預訂總額爲400萬美元。

  • 截至2024年5月31日,積壓訂單爲730萬美元。有效訂單,包括第四財季以後接收到的所有訂單,爲2080萬美元。

  • 截至2024年5月31日,現金及現金等價物總額爲4920萬美元,高於2024年2月29日的4760萬美元。

Fiscal Year Financial Results:

財政年度財務業績:

  • Net revenue was a record $66.2 million, compared to $65.0 million in fiscal 2023

  • GAAP net income was $33.2 million, or $1.12 per diluted share, which includes the impact of a tax benefit resulting from the release of the Company's full income tax valuation allowance of approximately $20.8 million recognized in the fourth quarter, compared to GAAP net income of $14.6 million, or $0.50 per diluted share, in fiscal 2023.

  • Non-GAAP net income, which includes the tax benefit and excludes acquisition related costs and the impact of stock-based compensation, was $35.8 million, or $1.21 per diluted share, compared to non-GAAP net income of $17.3 million, or $0.59 per diluted share, in fiscal 2023.

  • 淨營業收入創下記錄,爲6620萬美元,在2023財年爲6500萬美元。

  • 根據GAAP,淨利潤爲3320萬美元,每股攤薄盈利爲1.12美元,其中包括公司扣除的約2080萬美元所得稅收益的影響,並在第四財季確認,而在2023財年根據GAAP的淨利潤爲1460萬美元,每股攤薄盈利爲0.50美元。

  • 根據非GAAP,淨利潤,包括所得稅收益並排除收購相關成本和股票補償的影響,爲3580萬美元,每股攤薄盈利爲1.21美元,而在2023財年根據非GAAP的淨利潤爲1730萬美元,每股攤薄盈利爲0.59美元。

An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr's non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.

關於使用非GAAP財務指標的解釋以及Aehr的非GAAP財務指標與最直接可比的GAAP財務指標的調節,可在隨附的表格中找到。

Gayn Erickson, President and CEO of Aehr Test Systems, commented:

Aehr Test Systems的總裁兼首席執行官Gayn Erickson評論道:

"Our full-year revenue and net income results exceeded our previously provided guidance and surpassed analyst consensus. Although we saw customer pushouts of silicon carbide devices due to slower electric vehicle (EV) demand in the second half of our fiscal year, we achieved another record year for annual revenue for Aehr.

「我們的全年營收和淨利潤業績超過了之前提供的指導,並超過了分析師的一致預期。雖然在我們的財年下半年,由於新能源車需求減緩,發現碳化硅器件的客戶推遲了交貨,但我們在Aehr刷新了年度營收記錄。」

"Wafer level test and burn-in of silicon carbide power semiconductors used in EVs was a key driver of our business in the last year, and we anticipate silicon carbide will continue to be a key contributor to revenue in the current fiscal year and beyond. To that point, we announced today that we received $12.7 million in orders from one of our silicon carbide test and burn-in customers for FOX WaferPak full wafer Contactors to support production of silicon carbide power devices for electric vehicles to be delivered over the next three months.

“在過去的一年中,碳化硅功率半導體在晶圓級測試和烤機方面是我們業務的一個關鍵驅動因素,我們預計碳化硅在目前財年和以後的年度營收中仍將作出重要貢獻。爲此,我們今天宣佈,我們從我們的一個碳化硅測試和烤機客戶那裏獲得1270萬美元的訂單,用於支持未來三個月內交付給新能源車的碳化硅功率器件的FOX WaferPak全晶圓接觸器。

"The silicon carbide market continues to be an enormous opportunity for Aehr as we see more auto suppliers committed to silicon carbide in their EVs, as well as roadmaps that are based on modules for their electric motor power inverters. By 2030, battery EVs are forecasted to more than triple last year's sales to 30 million or 30% of total vehicles manufactured worldwide.

“在未來,我們仍看好碳化硅市場機會。我們看到更多的汽車供應商致力於在其新能源汽車中使用碳化硅,以及以模塊爲基礎的電動機功率逆變器路線圖。到2030年,據預測,電動汽車銷量將增加到3000萬輛或全球汽車總銷量的30%。

"We remain actively engaged with a significant number of new silicon carbide device and module suppliers and seek to meet their anticipated capacity coming online beginning in 2025. We are also seeing growing demand for silicon carbide devices beyond the EV market, such as solar, data center, and other industrial applications for power conversion. We believe we are well positioned to continue to grow our business in silicon carbide, and we expect to receive first orders from a significant number of additional silicon carbide customers by the end of this fiscal year.

「我們與大量新的碳化硅器件和模塊供應商保持着積極聯繫,並有望滿足他們在2025年開始上線的預期容量。我們也看到在 EV 市場之外,例如太陽能、數據中心和其他用於功率轉換的工業應用,碳化硅器件的需求正在不斷增長。我們相信我們在碳化硅領域的業務發展前景良好,並預計在本財年結束前從大量其他碳化硅客戶處獲得首筆訂單。」

"We are also seeing traction with several emerging opportunities for our test and burn-in solutions in new target markets and expect bookings and revenue across a much broader range of customers and markets this fiscal year.

「我們還看到了一些新興市場機會的跡象,針對新的目標市場提供測試和烤機解決方案,並預計這一財年將在更廣泛的客戶和市場上產生預訂和收入。」

"One of the key new market opportunities we are focusing on is the growing demand for Artificial Intelligence (AI) processor test and burn-in at both the wafer level and the packaged part level.

「我們正在關注越來越多的人工智能(AI)處理器測試和烤機需求,既在晶圓級也在封裝部件級別。這是我們着重關注的一項新市場機會。」

"We are currently working with an AI accelerator company and have secured a commitment from them to evaluate our FOX solution for use in production wafer level burn-in of their high-power processors. Upon successful demonstration of wafer level test results and throughput, we expect they will utilize our new high-power FOX-XP systems for production of their next generation AI processors, starting this fiscal year.

我們目前正在與一家人工智能加速器公司合作,並已獲得他們承諾評估我們的FOX解決方案以用於其高功率處理器的晶圓級燒錄生產。在成功演示晶圓級測試結果和吞吐量後,我們預計他們將使用我們的新高功率FOX-XP系統在本財年開始生產它們的下一代人工智能處理器。

"We also announced today in a separate press release our acquisition of Incal Technology, a manufacturer of highly acclaimed reliability test and burn-in solutions of a wide range of semiconductor devices and markets, with a new product family of ultra-high-power test solutions for AI accelerators, graphics & network processors, and high-performance computing processors. We believe that between wafer level and package part, the reliability test and production burn-in market for AI processors exceeds $100 million annually, and with this combined product portfolio we believe we have the opportunity to capture a meaningful share of the market this fiscal year.

我們還在今天發佈了另一份新聞稿,宣佈我們已收購Incal Technology,一家生產廣受好評的可靠性測試和燒錄解決方案的半導體器件和市場製造商,該公司擁有針對人工智能加速器、圖形和網絡處理器和高性能計算處理器的新產品系列的超高功率測試解決方案。我們認爲,在晶圓級和封裝級的部件中,人工智能加速器的可靠性測試和生產燒錄市場每年超過1000萬美元,憑藉這個組合的產品組合,我們相信本財年有機會佔據市場的重要份額。

"This past year we announced our first order for a FOX wafer level test and burn-in system for gallium nitride (GaN) devices. While silicon carbide will be the semiconductor material of choice for EV traction inverters, GaN is expected to gain significant penetration in the on-board charging market as well as other automotive, solar, and data center power conversion applications. We are working with several of the GaN market leaders, and received a significant number of WaferPak orders throughout the year for gallium nitride reliability test and qualification. We have now received our first forecasts for wafer level production burn-in systems to be delivered during this fiscal year. We continue to be encouraged by this market and believe it will be significant in market size for semiconductors and has the potential to be a solid market opportunity for Aehr's solutions.

在過去的一年中,我們爲氮化鎵設備的FOX晶圓級測試和燒錄系統接到了我們的第一筆訂單。儘管碳化硅將成爲電動汽車牽引變流器的半導體材料選擇,但氮化鎵預計將在車載充電市場及其它汽車、太陽能和數據中心的電力轉換應用領域佔有重要地位。我們正在與幾家氮化鎵市場領導者合作,並在整個年度收到了大量氮化鎵可靠性測試和鑑定的晶圓包裝訂單。我們現在已經收到了首批晶圓級生產燒錄系統的預測,將在本財年內交付。我們繼續對該市場感到鼓舞,並相信它將在半導體市場中佔有重要地位,並具有成爲Aehr解決方案的良好市場機會的潛力。

"Within the silicon photonics market, we shipped the first order from a major silicon photonics customer for the new high-power configuration of our FOX-XP system this last fiscal year. This new configuration expands our market opportunity by enabling cost-effective volume production test of wafers of next-generation photonic ICs that are targeted for use in the new optical I/O or co-packaged optics market. Nvidia, AMD, and Intel have all discussed the potential for adding optical chip-to-chip communication for performance improvement and power savings for AI processors and High-Performance Computing chips.

在硅光子市場內,我們在上個財年向一家主要的硅光子客戶發貨了我們FOX-XP系統新的高功率配置的第一筆訂單。這種新配置擴大了我們的市場機會,通過實現成本效益的大規模生產測試下一代光子集成電路,該光子集成電路旨在用於新的光學 I/O 或爲硅片上的光學底包涵蓋市場。英偉達、AMD和英特爾都討論過爲人工智能處理器和高性能計算芯片添加光學芯片對芯片之間通信的潛力,以實現性能提升和節能。

"Looking ahead, we believe Aehr has significant opportunities for growth in fiscal 2025 and beyond with our industry-leading product portfolio, and we look forward to updating you on our progress throughout the year as we seek to capitalize on these exciting new opportunities."

展望未來,我們相信Aehr在2025財年及之後擁有巨大的增長機會,憑藉我們領先行業的產品組合,我們期待在整個一年中更新我們的進展情況,並利用這些令人興奮的新機會。

Fiscal 2025 Financial Guidance:

2025財年財務指導:

For the fiscal year ending May 30, 2025, Aehr expects total revenue of at least $70 million and net profit before taxes of at least 10% of revenue.

對於截至2025年5月30日的財年,Aehr預計總營業收入至少爲7000萬美元,稅前淨利潤至少佔收入的10%。

Management Conference Call and Webcast:

管理層電話會議和網絡研討會:

Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its fiscal 2024 fourth quarter and full year operating results. To access the live call, dial +1 888-506-0062 (US and Canada) or +1 973-528-0011 (International) and give the participant passcode 196310.

Aehr Test Systems將於今天下午5:00(美東時間2:00 p.m.)舉行電話會議和網絡研討會,討論其2024年第四季度和全年業務運營結果。要進入現場會議,請撥打+1 888-506-0062(美國和加拿大)或+1 973-528-0011(國際)並提供參會人員通行證號碼196310。

In addition, a live and archived webcast of the conference call will be available over the Internet at in the Investor Relations section and may also be accessed by clicking here. A phone replay of the conference call will also be available beginning approximately two hours after conclusion of the live call and will remain available for one week. To access the call replay, dial +1 877-481-4010 (US and Canada) or +1 919-882-2331 (International) and enter replay passcode 50772.

此外,電話會議的現場和存檔網絡研討會將在投資者關係部分提供,並可以通過單擊此處進行訪問。約兩個小時後,會議呼叫的電話回放也將提供,並將保持一週。要進入呼叫重放,請撥打+1 877-481-4010(美國和加拿大)或+1 919-882-2331(國際),並輸入回放通行證號碼50772。

About Aehr Test Systems

aehr@mkr-group.com

Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer level, singulated die, and package part form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, data and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products and solutions. Aehr has developed and introduced several innovative products including the FOX-P families of test and burn-in systems and FOX WaferPak Aligner, FOX WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. For more information, please visit Aehr Test Systems' website at .

Aehr Test Systems總部位於加利福尼亞州弗裏蒙特,是半導體器件在晶圓級、獨立晶片和封裝件中的測試解決方案的領先供應商,已在全球安裝了數千台系統。半導體在多個應用中的質量、可靠性、安全性和安全性的需求(包括電動汽車、電動汽車充電基礎設施、太陽能和風力發電、計算、數據和電信基礎設施以及固態記憶卡和存儲)正在推動額外的測試需求、增量容量需求和Aehr測試產品和解決方案的新機遇。Aehr已經開發並推出了幾種創新產品,包括FOX-P系列測試和燒錄系統,FOX WaferPak Aligner,FOX WaferPak Contactor,FOX DiePak Carrier和FOX DiePak Loader。FOX-XP和FOX-NP系統是晶圓式接觸和獨立晶片/模塊測試和燒錄系統,可測試、燒錄和穩定廣泛的器件,例如最先進的碳化硅和其它電源半導體、用於手機、平板電腦和其它計算設備中的2D和3D傳感器、存儲器半導體、處理器、微控制器、系統芯片以及光子和集成光學器件。FOX-CP系統是低成本的邏輯、存儲器和光子器件單晶圓緊湊型測試解決方案,是FOX-P產品系列的最新成員。FOX WaferPak Contactor包含一種獨特的全晶圓接觸器,可測試直徑高達300毫米的晶圓,使IC製造商能夠在FOX-P系統上對全晶圓進行測試、燒錄和穩定。FOX DiePak Carrier允許在FOX-NP和FOX-XP系統上對高達1024個裸核和模塊進行測試、燒錄和穩定,每個DiePak最多可以同時使用九個DiePak。有關更多信息,請訪問Aehr Test Systems網站。

Safe Harbor Statement

Safe Harbor聲明

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr's expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, future requirements and orders of Aehr's new and existing customers; bookings and revenue forecasted for proprietary WaferPak and DiePak consumables, as well as the ability to generate bookings and revenue from application of Aehr's solutions in emerging markets; Aehr's ability to receive orders and generate revenue in the future, as well as Aehr's beliefs regarding the factors impacting the foregoing; preliminary financial guidance for the full fiscal year 2024; and expectations related to long-term demand for Aehr's products, the attractiveness of key markets and the ability for AEHR to successfully enter new markets. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr's recent Form 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.

本新聞稿包含某些根據《1933年證券法》第27A條和《1934年證券交易法》第21E條而做出的前瞻性聲明。前瞻性聲明通常涉及未來事件或Aehr的未來財務或經營績效。在某些情況下,您可以通過其中包含「可能」、「將」、「應該」、「預計」、「計劃」、「期望」、「將」、「可以」、「有意」、「目標」、「項目」、「考慮」、「相信」、「估計」、「預測」、「潛力」或「繼續」等詞或其他類似用語或表達方式來識別前瞻性聲明,這些前瞻性聲明涉及Aehr的期望、戰略、優先事項、計劃或意圖。本新聞稿中的前瞻性聲明包括但不限於Aehr新客戶和既有客戶的未來需求和訂單;專有WaferPak和DiePak消耗品的訂單和收入預測,以及應用Aehr解決方案在新興市場上產生訂單和收入的能力;Aehr將來接收訂單並生成收入的能力,以及Aehr對影響前述因素的信念;2024財年的初步財務指導;以及與Aehr的產品的長期需求、關鍵市場的吸引力以及AEHR成功進入新市場的能力有關的期望。本新聞稿中包含的前瞻性聲明也受到其他風險和不確定性的影響,包括更全面地描述在最近提交的10-K、10-Q和其他報告中的其他風險和不確定性。Aehr不承諾更新任何前瞻性聲明中包含的信息,以反映本新聞稿日期之後發生的事件或情況。

Contacts:

聯繫人:

Aehr Test Systems

MKR Investor Relations Inc.

Chris Siu

Todd Kehrli or Jim Byers

Chief Financial Officer

Analyst/Investor Contact

csiu@aehr.com

(323) 468-2300

aehr@mkr-group.com

aehr test systems公司

MKR Investor Relations公司

Chris Siu

Todd Kehrli或Jim Byers

致富金融(臨時代碼)

分析師/投資者聯繫方式

csiu@aehr.com

(323)468-2300

aehr@mkr-group.com

- Financial Tables to Follow -

- 財務表將隨後發佈 -

AEHR TEST SYSTEMS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

aehr test systems
簡明合併利潤表
(未經審計)

Three Months Ended

Year Ended

May 31,

Feb 29,

May 31,

May 31,

May 31,

(In thousands, except per share data)

2024

2024

2023

2024

2023

Revenue:
Product

$

15,805

$

6,730

$

21,002

$

61,729

$

60,717

Services

795

833

1,267

4,489

4,244

Total revenue

16,600

7,563

22,269

66,218

64,961

Cost of revenue:
Product (1)

7,519

3,948

10,020

31,093

29,759

Services (1)

633

459

770

2,582

2,456

Total cost of revenue

8,152

4,407

10,790

33,675

32,215

Gross profit

8,448

3,156

11,479

32,543

32,746

Operating expenses:
Research and development

2,151

2,139

2,253

8,719

7,134

Selling, general and administrative

3,756

3,063

3,587

13,746

12,237

Total operating expenses

5,907

5,202

5,840

22,465

19,371

Income (loss) from operations

2,541

(2,046)

5,639

10,078

13,375

Interest income, net

592

584

487

2,388

1,245

Other expense, net
(10) (2) (4) (8) (3)
Income (loss) before income tax expense (benefit)

3,123

(1,464)

6,122

12,458

14,617

Income tax expense (benefit)
(20,741)

7

11

(20,698)

60

Net income (loss)

$

23,864

$

(1,471)

$

6,111

$

33,156

$

14,557

Net income (loss) per share:
Basic

$

0.82

$

(0.05)

$

0.21

$

1.15

$

0.52

Diluted

$

0.81

$

(0.05)

$

0.21

$

1.12

$

0.50

Shares used in per share calculations:
Basic

28,953

28,866

28,425

28,818

27,785

Diluted

29,459

28,866

29,572

29,617

29,215

三個月之內結束

截止年份

5月31日

2月29日

5月31日

5月31日

5月31日

(以千爲單位,除每股數據外)

2024

2024

2023

2024

2023

營業收入:
產品

$

15,805

$

6,730

$

21,002

$

61,729

$

60,717

服務

795

833

1,267

4,489

4,244

總收入

16,600

7,563

22,269

66,218

64,961

營業成本:
產品(1)

7,519

3,948

10,020

31,093

29,759

服務 (1)

633

459

770

2,582

2,456

營業成本總額

8,152

4,407

10,790

33,675

32,215

毛利潤

8,448

3,156

11,479

32,543

32,746

營業費用:
研發

2,151

2,139

2,253

8,719

7,134

銷售、一般及行政費用

3,756

3,063

3,587

13,746

12,237

營業費用總計

5,907

5,202

5,840

22,465

19,371

營業收支(虧損)

2,541

(2,046)

5,639

10,078

13,375

利息收入,淨額

592

584

487

2,388

1,245

其他費用,淨額
(10) (2) (4) (8) (3)
所得稅前收益(虧損)

3,123

(1,464)

6,122

12,458

14,617

所得稅費用(收益)
(20,741)

7

11

(20,698)

60

淨利潤(損失)

$

23,864

$

(1,471)

$

6111

$

33,156

$

14,557

淨利潤每份股息:
基本

$

0.82

$

(0.05)

$

0.21

$

1.15

$

0.52

攤薄

$

0.81

$

(0.05)

$

0.21

$

1.12

$

0.50

用於每股計算的股份數:
基本

28,953

28,866

28,425

28,818

27,785

攤薄

29,459

28,866

29,572

29,617

29,215

(1) Certain amounts in a prior period have been reclassified to conform to the current period presentation.

(1)在前期的某些金額已重新分類以符合當前期間的報表格式。

AEHR TEST SYSTEMS
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(Unaudited)

aehr test systems
GAAP與非GAAP結果的對比調和
(未經審計)

Three Months Ended

Year Ended

May 31,

Feb 29,

May 31,

May 31,

May 31,

(In thousands, except per share data)

2024

2024

2023

2024

2023

Reconciliation of GAAP to non-GAAP gross profit
GAAP gross profit

$

8,448

$

3,156

$

11,479

$

32,543

$

32,746

Special items:
a) Stock-based compensation expense

108

58

79

330

331

Non-GAAP gross profit

$

8,556

$

3,214

$

11,558

$

32,873

$

33,077

Reconciliation of GAAP to non-GAAP operating expenses
GAAP operating expenses

$

5,907

$

5,202

$

5,840

$

22,465

$

19,371

Special items:
a) Stock-based compensation expense
(667) (525) (574) (2,188) (2,417)
b) Acquisition related costs
(107)

-

-

(107)

-

Non-GAAP operating expenses

$

5,133

$

4,677

$

5,266

$

20,170

$

16,954

Reconciliation of GAAP to non-GAAP income (loss) from operations
GAAP income (loss) from operations

$

2,541

$

(2,046)

$

5,639

$

10,078

$

13,375

Special items:
a) Stock-based compensation expense

775

583

653

2,518

2,748

b) Acquisition related costs

107

-

-

107

-

Non-GAAP (loss) income from operations

$

3,423

$

(1,463)

$

6,292

$

12,703

$

16,123

Reconciliation of GAAP to non-GAAP income (loss) before income tax expense (benefit)
GAAP income (loss) before income tax expense (benefit)

$

3,123

$

(1,464)

$

6,122

$

12,458

$

14,617

Special items:
a) Stock-based compensation expense

775

583

653

2,518

2,748

b) Acquisition related costs

107

-

-

107

-

Non-GAAP income (loss) before income tax expense (benefit)

$

4,005

$

(881)

$

6,775

$

15,083

$

17,365

Reconciliation of GAAP to non-GAAP net income (loss)
GAAP net income (loss)

$

23,864

$

(1,471)

$

6,111

$

33,156

$

14,557

Special items:
a) Stock-based compensation expense

775

583

653

2,518

2,748

b) Acquisition related costs

107

-

-

107

-

Non-GAAP net income (loss)

$

24,746

$

(888)

$

6,764

$

35,781

$

17,305

Reconciliation of GAAP net income (loss) per diluted share to non-GAAP net income (loss) per diluted share
GAAP net income (loss) per diluted share

$

0.81

$

(0.05)

$

0.21

$

1.12

$

0.50

Special items:
a) Stock-based compensation expense

0.03

0.02

0.02

0.09

0.09

b) Acquisition related costs

0.00

-

-

0.00

-

Non-GAAP net income (loss) per diluted share

$

0.84

$

(0.03)

$

0.23

$

1.21

$

0.59

三個月之內結束

截止年份

5月31日

2月29日

5月31日

5月31日

5月31日

(以千爲單位,除每股數據外)

2024

2024

2023

2024

2023

毛利潤的GAAP與非GAAP結果對比調和
GAAP毛利潤

$

8,448

$

3,156

$

11,479

$

32,543

$

32,746

特別項目:
a)基於股票的補償費用

108

58

79

330

331

非通用會計原則毛利潤

$

8,556

$

3,214

$

11,558

$

32,873

$

33,077

GAAP和非GAAP營業費用的調節
GAAP營業費用

$

5,907

$

5,202

$

5,840

$

22,465

$

19,371

特別項目:
a)基於股票的補償費用
(667) (525) (574) (2,188) (2,417)
b)併購相關成本
(107)

-

-

(107)

-

非GAAP營業費用

$

5,133

$

4,677

$

5,266

$

20,170

$

16,954

GAAP和非GAAP營業收入(虧損)的調節
通用會計制度下的業務利潤

$

2,541

$

(2,046)

$

5,639

$

10,078

$

13,375

特別項目:
a)基於股票的補償費用

775

583

653

2,518

2,748

b)併購相關成本

107

-

-

107

-

非GAAP營業收入(虧損)

$

3,423

$

(1,463)

$

6,292

$

12,703

$

16,123

GAAP和非GAAP稅前收入(虧損)的調節
GAAP稅前收入(虧損)

$

3,123

$

(1,464)

$

6,122

$

12,458

$

14,617

特別項目:
a)基於股票的補償費用

775

583

653

2,518

2,748

b)併購相關成本

107

-

-

107

-

非GAAP稅前收入(虧損)

$

4,005

$

(881)

$

6,775

$

15,083

$

17,365

GAAP淨利潤(虧損)與非GAAP淨利潤(虧損)的調節
GAAP淨利潤(損失)

$

23,864

$

(1,471)

$

6111

$

33,156

$

14,557

特別項目:
a)基於股票的補償費用

775

583

653

2,518

2,748

b)併購相關成本

107

-

-

107

-

非GAAP淨收入(淨虧損)

$

24,746

$

(888)

$

6,764

$

35,781

$

17,305

GAAP稀釋後每股淨收益(虧損)與非GAAP稀釋後每股淨收益(虧損)的調節
GAAP稀釋後每股淨收益(虧損)

$

0.81

$

(0.05)

$

0.21

$

1.12

$

0.50

特別項目:
a)基於股票的補償費用

0.03

0.02

0.02

0.09

0.09

b)收購相關成本

0.00

-

-

0.00

-

非GAAP稀釋後每股淨收益(虧損)

$

0.84

$

(0.03)

$

0.23

$

1.21

$

0.59

a) Represents compensation expense for equity awards granted to employees and directors
b) Represents acquisition activity costs
Non-GAAP measures should not be considered a replacement for GAAP results. The non-GAAP measures indicated above are financial measures the Company uses to evaluate the underlying results and operating performance of the business. The limitation of these measures are that they exclude items that impact the Company's current period GAAP measures. This limitation is best addressed by using these measures in combination with the most directly comparable GAAP financial measures. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.
We believe these measures enhance investors' ability to review the Company's business from the same perspective as the Company's management and facilitate comparisons of this period's results with prior periods.

a)代表授予僱員和董事的股權獎勵的補償費用
b)代表收購活動費用
非GAAP衡量指標不應被視爲GAAP結果的替代品。上述非GAAP衡量指標是公司用於評估業務的基礎結果和運營績效的財務衡量指標。這些衡量指標的侷限性在於,它們排除影響公司當期GAAP衡量指標的項目。最好結合最直接可比較的GAAP財務衡量指標來解決這種侷限性。這些衡量指標不符合GAAP的要求,可能與其他公司使用的非GAAP會計和報告方法不同。
我們相信這些衡量指標增強了投資者從公司管理的同一視角審查公司業務的能力,並促進了本期結果與之前期間結果的比較。

AEHR TEST SYSTEMS
CONSOLIDATED BALANCE SHEETS
(Unaudited)

aehr test systems
基本報表
(未經審計)

May 31,

(In thousands, except par value)

2024

2023

ASSETS
Current assets:
Cash and cash equivalents

$

49,159

$

30,054

Short-term investments

-

17,853

Accounts receivable, net

9,796

16,594

Inventories

37,470

23,908

Prepaid expenses and other current assets

1,423

621

Total current assets

97,848

89,030

Property and equipment, net

3,253

2,759

Operating lease right-of-use assets, net

5,734

6,123

Deferred tax assets, net

20,773

-

Other non-current assets

304

231

Total assets

127,912

98,143

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable

$

5,332

$

9,206

Accrued expenses

3,366

4,143

Operating lease liabilities, short-term

465

137

Deferred revenue, short-term

1,345

2,822

Total current liabilities

10,508

16,308

Operating lease liabilities, long-term

5,732

6,163

Deferred revenue, long-term

41

31

Other long-term liabilities

38

41

Total liabilities

16,319

22,543

Shareholders' equity:
Preferred stock, $0.01 par value: Authorized: 10,000 shares;
Issued and outstanding: none

-

-

Common stock, $0.01 par value: Authorized: 75,000 shares;
Issued and outstanding: 28,995shares and 28,539 shares at May 31, 2024 and 2023, respectively

289

285

Additional paid-in-capital

130,612

127,776

Accumulated other comprehensive loss
(158) (155)
Accumulated deficit
(19,150) (52,306)
Total shareholders' equity

111,593

75,600

Total liabilities and shareholders' equity

$

127,912

$

98,143

5月31日

(以千爲單位,除每股面值外)

2024

2023

資產
流動資產:
現金及現金等價物

$

49,159

$

30,054

短期投資

-

17,853

應收賬款淨額

9,796

16,594

存貨

37,470

23,908

資產預付款和其他流動資產的變動

1,423

621

總流動資產

97,848

89,030

資產和設備,淨值

3,253

2,759

經營租賃使用權資產,淨值

5,734

6,123

遞延所得稅資產,淨額

20,773

-

其他非流動資產

304

231

總資產

127,912

98,143

負債和股東權益
流動負債:
應付賬款

$

5,332

$

9,206

應計費用

3,366

4,143

短期經營租賃負債

465

137

短期遞延收入

1,345

2,822

流動負債合計

10,508

16,308

經營租賃負債,長期

5,732

6,163

長期遞延營業收入

41

31

其他長期負債

38

41

負債合計

16,319

22,543

股東權益:
優先股,每股0.01美元票面價值:授權:10,000股;
已發行但未流通:無

-

-

普通股,每股0.01美元票面價值:授權:75,000股;
已發行股份數量:分別爲2024年5月31日和2023年5月31日的28,995股和28,539股

289

285

股本溢價

130,612

127,776

累計其他綜合損失
(158) (155)
累積赤字
(19,150) (52,306)
股東權益合計

111,593

75,600

負債和股東權益合計

$

127,912

$

98,143

AEHR TEST SYSTEMS
CONSOLIDATED STATEMENT OF CASH FLOWS
(Unaudited)

aehr test systems
現金流量表合併報表
(未經審計)

Year Ended May 31,

(In thousands)

2024

2023

Cash flows from operating activities:
Net income

$

33,156

$

14,557

Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense

2,518

2,748

Depreciation and amortization

657

450

Deferred income taxes
(20,773)

-

Accretion of investment discount
(130) (576)
Amortization of operating lease right-of-use assets (2)

706

649

Provision for credit loss

-

24

Changes in operating assets and liabilities:
Accounts receivable

6,790

(3,788)
Inventories
(13,732) (9,469)
Prepaid expenses and other current assets
(875)

28

Accounts payable
(3,891)

5,044

Accrued expenses
(792)

528

Deferred revenue
(1,469)

369

Operating lease liabilities (2)
(423) (561)
Income taxes payable

14

8

Net cash provided by operating activities

1,756

10,011

Cash flows from investing activities:
Proceeds from maturities of investments

18,000

16,000

Purchases of investments

-

(33,294)
Purchases of property and equipment
(749) (1,362)
Net cash provided by (used in) investing activities

17,251

(18,656)
Cash flows from financing activities:
Proceeds from issuance of common stock under employee plans

1,807

2,562

Shares repurchased for tax withholdings on vesting of restricted stock units
(1,596) (2,060)
Proceeds from issuance of common stock, net of issuance costs
(72)

6,820

Net cash provided by financing activities

139

7,322

Effect of exchange rate changes on cash, cash equivalents and restricted cash
(41) (37)
Net increase (decrease) in cash, cash equivalents and restricted cash

19,105

(1,360)
Cash, cash equivalents and restricted cash, beginning of year (1)

30,204

31,564

Cash, cash equivalents and restricted cash, end of year (1)

$

49,309

$

30,204

Supplemental cash flow information:
Income taxes paid

90

21

Interest paid

-

15

Supplemental disclosure of non-cash flow information:
Net transfer of equipment between inventory and property and equipment

357

646

截至2021年5月31日

(以千爲單位)

2024

2023

經營活動現金流量:
淨收入

$

33,156

$

14,557

調整淨利潤以計入經營活動現金流量:
股票補償費用

2,518

2,748

折舊和攤銷

657

450

延遲所得稅
(20,773)

-

投資折價的累計攤銷
(130) (576)
運營租賃權益資產攤銷(2)

706

649

信用損失撥備

-

24

經營性資產和負債變動:
應收賬款

6,790

(3,788)
存貨
(13,732) (9,469)
資產預付款和其他流動資產的變動
(875)

28

應付賬款
(3,891)

5,044

應計費用
(792)

528

遞延收入
(1,469)

369

經營租賃負債 (2)
(423) 988-3600
應付所得稅

14

8

經營活動產生的現金流量淨額

1,756

10,011

投資活動現金流量:
投資到期收回款

18,000

16,000

投資購買

-

(33,294)
購買固定資產
(749) (1,362)
投資活動產生的淨現金流量

17,251

(18,656)
籌集資金的現金流量:
通過員工計劃發行普通股所得

1,807

2,562

爲扣減限制性股票單位解除而回購的股份
(1,596) (2,060)
發行普通股票收益,扣除發行費用淨額
(72)

6,820

籌資活動產生的現金淨額

139

7,322

匯率變動對現金、現金等價物及受限制資金的影響
(41) (37)
現金、現金等價物及受限制的現金流動淨增長額(減少額)

19,105

(1,360)
現金、現金等價物和受限制的現金,年初 (1)

30,204

31,564

現金、現金等價物和受限制的現金,年末 (1)

$

49,309

$

30,204

補充現金流量信息:
所得稅已付款項

90

21

支付的利息

-

15

非現金流量信息的補充披露:
設備在庫存與固定資產之間的淨轉移

357

646

(1) Includes restricted cash in other non-current assets.
(2) Certain amounts in a prior period have been reclassified to conform to the current period presentation.

(1) 包括其他非流動資產中受限制的現金。
(2) 先前期間的某些金額已被重新分類以符合當前期間的呈現要求。

SOURCE: Aehr Test Systems

資料來源:Aehr Test Systems


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論